Suppr超能文献

与接受多疗程皮质类固醇治疗的孕妇相比,接受单疗程皮质类固醇治疗的孕妇的骨代谢情况。

Bone metabolism in pregnant women exposed to single compared with multiple courses of corticosteroids.

作者信息

Carroll Mary A, Vidaeff Alex C, Mele Lisa, Wapner Ronald J, Mercer Brian, Peaceman Alan M, Sorokin Yoram, Dudley Donald J, Spong Catherine Y, Leveno Kenneth J, Harper Margaret, Caritis Steve N, Miodovnik Menachem, Thorp John M, Moawad Atef, O'Sullivan Mary J, Carpenter Marshall W, Rouse Dwight J, Sibai Baha

机构信息

Department of Obstetrics and Gynecology, University of Texas Houston, Houston, Texas 77030, USA.

出版信息

Obstet Gynecol. 2008 Jun;111(6):1352-8. doi: 10.1097/AOG.0b013e318173573b.

Abstract

OBJECTIVE

To compare markers of maternal bone metabolism between women who received a single compared with multiple courses of antenatal corticosteroids.

METHODS

This is an analysis of serum samples from a previously reported randomized, placebo-controlled, multicenter trial. Women at risk for preterm delivery after an initial course of corticosteroids were randomly assigned to weekly courses of betamethasone (active) or placebo. Serum levels of carboxy terminal propeptide of type I procollagen (PICP) and cross-linked carboxy terminal telopeptide of type I collagen (ICTP) were measured to assess the rate of bone formation and resorption, respectively, at three time points. The placebo group (n=93) was compared with the active group, receiving four or more courses of betamethasone (n=112).

RESULTS

There were significant (P<.001) increases in PICP and ICTP between baseline and delivery in both groups. Cross-linked carboxy terminal telopeptide of type I collagen, but not PICP, was lower with corticosteroid exposure immediately before administration of the fourth study course (P<.001). No significant differences in PICP and ICTP were seen between groups at delivery.

CONCLUSION

Increasing levels of PICP and ICTP with advancing gestation are consistent with physiologic changes in maternal bone metabolism. Multiple courses of corticosteroids for fetal maturation are not associated with persistent or cumulative effects on maternal bone metabolism as measured by PICP and ICTP.

LEVEL OF EVIDENCE

II.

摘要

目的

比较接受单次与多次产前糖皮质激素疗程的女性的母体骨代谢标志物。

方法

这是一项对先前报道的随机、安慰剂对照、多中心试验的血清样本分析。在接受初始糖皮质激素疗程后有早产风险的女性被随机分配接受每周一次的倍他米松(活性药物)或安慰剂疗程。在三个时间点测量血清I型前胶原羧基末端前肽(PICP)和I型胶原交联羧基末端肽(ICTP)水平,分别评估骨形成和骨吸收速率。将安慰剂组(n = 93)与接受四个或更多疗程倍他米松的活性组(n = 112)进行比较。

结果

两组在基线和分娩之间PICP和ICTP均有显著升高(P <.001)。在第四次研究疗程给药前立即暴露于糖皮质激素的情况下,I型胶原交联羧基末端肽(而非PICP)较低(P <.001)。分娩时两组之间PICP和ICTP未见显著差异。

结论

随着孕周增加,PICP和ICTP水平升高与母体骨代谢的生理变化一致。用于胎儿成熟的多次糖皮质激素疗程与通过PICP和ICTP测量的母体骨代谢的持续或累积效应无关。

证据级别

II级。

相似文献

6
The relationship of fetal serum markers of bone metabolism to gestational age.
Early Hum Dev. 1998 May 29;51(2):109-12. doi: 10.1016/s0378-3782(97)00099-6.
8
Maternal and fetal plasma levels of markers of bone metabolism in gestational diabetic pregnancies.
Early Hum Dev. 1998 Dec;53(2):155-61. doi: 10.1016/s0378-3782(98)00048-6.
9
Antenatal corticosteroid therapy and risk of osteoporosis.
Br J Obstet Gynaecol. 1998 May;105(5):551-5. doi: 10.1111/j.1471-0528.1998.tb10157.x.

本文引用的文献

2
Bone in the pregnant mother and newborn at birth.怀孕母亲和新生儿出生时的骨骼。
Clin Chim Acta. 2003 Jul 1;333(1):1-11. doi: 10.1016/s0009-8981(02)00025-6.
3
Single versus repetitive courses of corticosteroids: what do we know?
Clin Obstet Gynecol. 2003 Mar;46(1):161-73. doi: 10.1097/00003081-200303000-00020.
8
Are we prescribing multiple courses of antenatal corticosteroids? A survey of practice in the UK.
BJOG. 2000 Apr;107(4):577-8. doi: 10.1111/j.1471-0528.2000.tb13290.x.
9
Are we prescribing multiple courses of antenatal corticosteroids? A survey of practice in the UK.
BJOG. 2000 Mar;107(3):434-5. doi: 10.1111/j.1471-0528.2000.tb13249.x.
10
The effect of pregnancy on bone density and bone turnover.妊娠对骨密度和骨转换的影响。
J Bone Miner Res. 2000 Jan;15(1):129-37. doi: 10.1359/jbmr.2000.15.1.129.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验